Delving into the Latest Updates on Himont, Inc. with Synapse

概览

排名前五的药物类型	数量

小分子化药	1

排名前五的靶点	数量

Cav2.1	1

关联

1

项与 Himont, Inc. 相关的药物

Lercanidipine Hydrochloride

盐酸乐卡地平

靶点

Cav2.1

作用机制

Cav2.1抑制剂

在研机构

Recordati SpA [+13]

原研机构

Meda AB

在研适应症

高血压

非在研适应症-

最高研发阶段批准上市

首次获批国家/地区

瑞典

首次获批日期1998-03-28

100 项与 Himont, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Himont, Inc. 相关的专利（医药）

登录后查看更多信息

10

项与 Himont, Inc. 相关的文献（医药）

1995-10-01·Macromolecular Symposia

High performance polyolefins: The new way towards engineering plastics applications

作者: J. C. Haylock ; A. Denicola ; P. Galli

A review with 4 references on high performance polyolefins, including Ziegler-Natta catalysts and alloys.

1988-01-01·Acta Polymerica

New frontiers in polymers blends: The synthesis alloys

作者: Del Duca, D. ; Simonazzi, T. ; Galli, P.

AbstractNew catalyst systems for the synthesis of polypropylene and polypropylene copolymers have been developed. The growth mechanisms of morphological structure of the polymers and some features of the process are described. Some properties of the obtained homopolymers and copolymers are presented, and the advantages and future developments of the process technology are discussed.

1987-12-01·American Industrial Hygiene Association journal

Health protection in an international industrial setting.

Article

作者: Giacco, A

100 项与 Himont, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Himont, Inc. 相关的转化医学

登录后查看更多信息